Selbyville, Delaware, Sept. 10, 2019 (GLOBE NEWSWIRE) --
U.S. rapid influenza diagnostic tests market was valued at USD 130.5 million in 2018 and is estimated to witness substantial amount of growth over the forecast period. The growth in the country is attributed to recent technological advancements and developments in the field of influenza diagnostics, presence of well-developed healthcare infrastructure and skilled professionals. Also, rising prevalence of influenza in the country will further boost the market growth. Growing government initiatives to build state-of-art infrastructure and facilities for manufacturing advanced technologies with the focus to deliver effective results for rapid influenza diagnostics testing will result in further enhancing the business growth in the country.
Use of rapid influenza diagnostic tests in hospitals is estimated to grow at 6.9% over the projection period. Hospitals are known to have state-of-the-art facilities along with trained healthcare professionals for conducting rapid influenza diagnostic tests. Also, there has been increase in preference of rapid influenza diagnostic testing for hospitalized patients owing to the ease of use, quick and better results provided. Increase in preference for hospital admissions by people in developing economies over other medical facilities will augment the growth of the market in the coming future.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/4329
Influenza A segment of rapid influenza diagnostic tests market is estimated to grow at 6.8% over the projection period. Rise in incidence of influenza across the globe will influence the market growth. There has been steady rise in the prevalence of influenza A and communicable respiratory disease. Influenza A is caused majorly due to the virus often known as bird flu or avian flu. Influenza A is more common and serious as compared to other influenza types such influenza B and C and known to cause prevalent epidemics. Hence, rise in influenza prevalence across the globe will boost the market growth.
Global Rapid Influenza Diagnostic Tests Market is projected to surpass USD 689 million by 2025; according to a new research study published by Global Market Insights, Inc. RIDT market is estimated to show considerable growth over the forthcoming years. The market growth is attributed to rising prevalence of influenza and related chronic diseases such as cardiovascular diseases and diabetes. According to the Centers for Disease Control and Prevention (CDC), influenza results in around 12,000 to 79,000 deaths in the U.S. annually. Moreover, growing awareness about several diagnostic tests for the diagnosis and prevention of influenza will augment market growth in the near future.
Increase in influenza prevalence across the globe will augment the rapid influenza diagnostic tests market growth in the near future. As per the World Health Organization (WHO), globally, annual epidemics of influenza are expected to result in around 4 million cases of severe illness, and about 47,000 respiratory deaths. Hence, growing number of people suffering from influenza will result in augmenting the demand and adoption rate of rapid influenza diagnostic tests, fueling the business growth.
Browse key industry insights spread across 110 pages with 89 market data tables & 9 figures & charts from the report, “Rapid Influenza Diagnostic Tests Market Size By Product (RIDT for Influenza A, RIDT for Influenza B), By Patient (Pediatric, Adult), By End-use (Hospitals, Diagnostics Centers, Research Laboratories) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/rapid-influenza-diagnostic-tests-ridt-market
However, stringent regulatory framework and guidelines regarding rapid influenza diagnostic tests, variability in specificity and sensitivity among influenza diagnostic tests will impede the growth of rapid influenza diagnostic tests market. Also, rising healthcare cost will act as a restraining factor for the market growth.
Rapid influenza diagnostic tests for pediatric was valued at around USD 99.5 million in the year 2018. Growing rate of hospitalization among the pediatric patient population without any underlying health conditions is high during the influenza season. Also, children with such underlying health conditions are more and more susceptible to seasonal influenza. As per the Centers for Disease Control and Prevention (CDC), as of April 2019, total of 186 pediatric deaths have been reported due to influenza in the U.S. Hence, growing influenza prevalence in children will increase the use of rapid influenza diagnostics tests in the pediatric patient pool, fueling the market growth.
Some of the significant market players involved in the rapid influenza diagnostic tests market includes DiaSorin S.p, BD, SA Scientific, CorisBioconcep among other players. These players aim to implement several strategic initiatives such as collaborations, mergers, acquisitions and partnerships to increase revenue generation and expand the product portfolio. For instance, in September 2016, Becton Dickinson and Company launched wireless diagnostic system BD Veritor Plus for detecting influenza virus and respiratory syncytial virus. This strategic initiative helped the company in expanding and broadening its product portfolio.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/4329
Browse Related Reports:
Influenza Diagnostic Tests Market By Patient (Pediatric {0 to 4 years, 5 to 17 years}, Adult {18 to 49 years, 50 to 64 years, 65+ years}), By End-use (Hospitals, Diagnostics Centers, Research Laboratories), By Influenza Type (Type A Flu, Type B Flu), By Test Type (Traditional Diagnostic Test {Rapid Influenza Diagnostic Test (RIDT), Direct Fluorescent Antibody Test (DFAT), Viral Culture, Serological Assay}, Molecular Diagnostic Assay {RT-PCR, Loop-mediated Isothermal Amplification-based Assay (LAMP), Nucleic Acid Sequence-based Amplification Test (NASBAT), Simple Amplification-based Assay (SAMBA)}), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025
https://www.gminsights.com/industry-analysis/influenza-diagnostic-tests-market
Global Vaccines Market By Technology (Conjugate, Attenuated, Inactivated, Recombinant, Toxoid), By Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Dengue, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus), By Age Group (Pediatric, Adult), Regional Outlook (U.S., Canada, Germany, UK, Spain, Russia, Italy, France, China, Japan, India, South Korea, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Qatar, Egypt), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025
https://www.gminsights.com/industry-analysis/vaccines-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.